V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008975 | 240005461 | 1.62 | 100.1 | Curative (C) | 2018-10-29 | 2018-10-30 | CVP R + GEMCITABINE | 02 | N | 240035558 | CISPLATIN + ETOPOSIDE |
| 240008976 | 240005462 | 1.69 | 81.6 | null | 2018-08-18 | 2018-08-19 | Cladribine (subcut) 5 days | null | N | 240035571 | CISPLATIN + GEMCITABINE |
| 240008977 | 240005462 | 1.51 | 61 | Adjuvant (A) | 2016-05-21 | 2016-06-19 | REMODLB TRIAL | 02 | N | 240035571 | CISPLATIN + ETOPOSIDE |
| 240008978 | 240005463 | 1.59 | 55 | Disease modification (D) | 2017-04-21 | 2017-04-21 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 240035615 | FLAG + IDARUBICIN |
| 240008979 | 240005463 | 1.65 | 87 | Curative (C) | 2017-04-06 | 2017-04-18 | CARBOPLATIN + GEMCITABINE | N | N | 240035615 | BEP |
| 240008980 | 240005463 | 1.6 | 59 | Curative (C) | null | 2016-11-10 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | Y | Y | 240035615 | FLAG + IDARUBICIN |
| 240008981 | 240005463 | null | 68.9 | Disease modification (D) | 2016-05-08 | 2016-05-20 | Cisplatin + Etoposide (3 day) | N | null | 240035615 | CISPLATIN + TOPOTECAN |
| 240008982 | 240005464 | 0 | 68.5 | Curative (C) | 2018-11-08 | 2018-11-08 | Cladribine (subcut) 5 days | 1 | N | 240005459 | CYTARABINE HD + METHOTREXATE HD |
| 240008983 | 240005464 | 1.85 | 84 | Palliative (P) | 2017-07-17 | 2017-07-24 | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 2 | N | 240005459 | FCR |
| 240008984 | 240005465 | null | 56.2 | Disease modification (D) | 2016-02-20 | 2016-02-29 | METHOTREXATE | null | N | 240006808 | GEMCARBO |
| 240008985 | 240005466 | 1.56 | 92.6 | null | 2018-06-10 | 2018-06-27 | Cisplatin + Topotecan | N | N | 240007272 | CYCLOPHOSPHAMIDE |
| 240008986 | 240011002 | null | null | Neo-adjuvant (N) | 2014-10-11 | 2014-10-11 | IDARUBICIN | N | N | 240009311 | CYTARABINE |
| 240008987 | 240013676 | 1.8 | 50 | Curative (C) | 2018-12-01 | 2018-12-01 | Methotrexate intrathecal | N | N | 240010921 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008988 | 240005467 | 1.83 | 84 | Curative (C) | 2016-12-23 | 2016-12-30 | IBRUTINIB | null | N | 240011081 | GEFITINIB |
| 240008989 | 240011003 | 1.77 | null | null | null | 2016-11-16 | Bortezomib + Cyclophos + Dex | N | null | 240011413 | BUSULPHAN |
| 240008990 | 240005468 | 0 | 66 | Curative (C) | 2016-12-24 | 2017-01-13 | Cyclophosphamide oral | null | N | 240011599 | BEVACIZUMAB |
| 240008991 | 240005469 | null | null | null | 2016-09-26 | 2016-10-03 | IDARAM | N | Y | 240011849 | GALLIUM TRIAL |
| 240008992 | 240005469 | 1.78 | 88.3 | Curative (C) | 2017-04-27 | 2017-05-04 | IDARUBICIN | N | N | 240011849 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008993 | 240005470 | 1.53 | null | Curative (C) | 2018-08-04 | 2018-08-24 | BLEOMYCIN + CISPLATIN + MITOMYCIN | N | N | 240013110 | BEVACIZUMAB |
| 240008994 | 240011005 | null | 64 | Palliative (P) | 2015-01-21 | 2015-02-10 | BEVACIZUMAB + CARBO + DOCETAXEL | N | N | 240013608 | BEVACIZUMAB + CARBO + DOCETAXEL |
| 240008995 | 240011005 | 1.69 | 57.9 | null | 2016-08-13 | 2016-08-27 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 240013608 | R-EPOCH |
| 240008996 | 240011005 | null | 73.8 | null | 2018-02-16 | 2018-02-21 | PEMBROLIZUMAB | N | N | 240013608 | CTD |
| 240008997 | 240011005 | null | null | Palliative (P) | null | 2014-11-27 | AML 18 TRIAL | null | null | 240013608 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 240008998 | 240005471 | 1.91 | 71 | Palliative (P) | 2017-12-06 | 2017-12-15 | Cyclophosphamide + Dex + Rituximab | N | null | 240015867 | GDP |
| 240008999 | 240005471 | 1.69 | 80 | Palliative (P) | 2013-09-28 | 2013-09-28 | GemCarbo Days 1+8 | 2 | N | 240015867 | CVD R |
| 240009000 | 240005472 | 1.65 | null | null | 2018-03-14 | 2018-04-01 | mEOC TRIAL | N | N | 240017130 | CISPLATIN + ETOPOSIDE |
| 240009001 | 240011007 | 0 | 112 | Palliative (P) | 2017-11-19 | 2017-11-22 | Cisplatin + Pemetrexed | N | N | 240017563 | CYCLOPHOSPHAMIDE |
| 240009002 | 240011007 | 1.83 | 69.4 | Neo-adjuvant (N) | 2019-03-24 | 2019-03-27 | R CODOX-M/ R IVAC | Y | N | 240017563 | NILOTINIB |
| 240009003 | 240005473 | 1.59 | 0 | Palliative (P) | 2016-06-06 | 2016-06-06 | CAPECITABINE + OXALIPLATIN | 02 | N | 240019083 | FLAG + IDARUBICIN |
| 240009004 | 240005473 | 1.73 | 101 | Palliative (P) | 2015-03-16 | 2015-03-20 | CYTARABINE + FLUDARABINE | null | N | 240019083 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240009005 | 240005474 | 1.79 | 63 | Palliative (P) | 2016-06-30 | 2016-11-14 | CHOEP | N | N | 240019885 | CVP |
| 240009006 | 240005474 | 1.73 | 67.1 | Curative (C) | 2014-03-20 | 2014-03-24 | Paclitaxel 7 day | N | N | 240019885 | CVP |
| 240009007 | 240013679 | 1.8 | 68 | Curative (C) | 2015-11-07 | 2015-11-21 | GEMCITABINE | N | N | 240020735 | METHOTREXATE INTRATHECAL |
| 240009008 | 240013679 | 1.68 | 67.7 | Adjuvant (A) | 2015-04-14 | 2015-04-16 | CHOEP | 2 | N | 240020735 | ALEMTUZUMAB |
| 240009009 | 240005475 | 1.75 | 103.7 | Not known (9) | 2017-10-29 | 2017-12-10 | GemCarbo Days 1+8 | 02 | N | 240021186 | CYTARABINE |
| 240009010 | 240005476 | 1.58 | 79.8 | Palliative (P) | 2018-05-11 | 2018-05-11 | CISPLATIN + GEMCITABINE + RITUXIMAB | N | null | 240021536 | FEC |
| 240009011 | 240005477 | null | null | Palliative (P) | 2018-07-25 | 2018-07-26 | FLAG + Idarubicin | 1 | N | 240021779 | LENALIDOMIDE |
| 240009012 | 240005478 | 1.83 | null | Disease modification (D) | 2017-01-24 | 2017-01-24 | Cytarabine intrathecal | N | N | 240021819 | VINCRISTINE |
| 240009013 | 240005479 | 1.84 | 67.4 | Palliative (P) | 2014-10-24 | 2014-11-03 | IDELALISIB + RITUXIMAB | null | N | 240022152 | FLAG + IDARUBICIN |
| 240009014 | 240005480 | 1.69 | 92.2 | Palliative (P) | 2016-05-26 | 2016-05-26 | Erlotinib | N | N | 240022190 | CYTARABINE HIGH DOSE |
| 240009015 | 240005481 | 1.64 | 65.9 | Palliative (P) | 2018-07-06 | 2018-07-06 | Cisplatin + Etoposide po&iv 3 day | N | N | 240022257 | CISPLATIN + ETOPOSIDE |
| 240009016 | 240011010 | null | 26.25 | Disease modification (D) | 2016-08-01 | 2016-08-18 | FCR Oral - Cycle 1 | N | N | 240022466 | GALLIUM TRIAL |
| 240009017 | 240005482 | null | null | Curative (C) | null | 2017-06-01 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 240022691 | CARBOPLATIN + PACLITAXEL + RT |
| 240009018 | 240005482 | 1.44 | 53.3 | Palliative (P) | 2014-10-04 | 2014-10-08 | Bevacizumab 15mg/kg | 02 | N | 240022691 | FCR |
| 240009019 | 240013680 | 1.62 | 62 | Disease modification (D) | 2018-08-27 | 2018-08-28 | NHL 2003 Gp B COP | N | N | 240023094 | R-EPOCH |
| 240009020 | 240013680 | 1.6 | 74.2 | Curative (C) | 2015-11-03 | 2015-11-07 | ABVD | N | Y | 240023094 | CISPLATIN + ETOPOSIDE |
| 240009021 | 240013680 | null | null | Palliative (P) | null | 2019-06-17 | PMitCEBO-R | N | null | 240023094 | FEC |
| 240009022 | 240005483 | 1.82 | 0 | Not known (9) | 2015-10-03 | 2015-10-03 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 240023957 | MATRIX TRIAL |
| 240009023 | 240005484 | 1.63 | 69.8 | Disease modification (D) | 2015-12-09 | 2015-12-10 | FCR Oral - Cycle 1 | 2 | N | 240024996 | CISPLATIN + FLUOROURACIL + RT |
| 240009024 | 240005484 | -1 | null | Curative (C) | 2017-02-03 | 2017-02-11 | FCR IV - Cycle 1 | N | N | 240024996 | AML16 TRIAL |